(VIANEWS) - EuroDry Ltd. (EDRY), Pfizer (PFE), Fresenius Medical Care AG (FMS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. EuroDry Ltd. (EDRY)
164.8% sales growth and 6.14% return on equity
EuroDry Ltd., through its subsidiaries, provides ocean-going transportation services worldwide.
EuroDry Ltd.'s sales growth this year is anticipated to be 165.5% and 14.3% for next year.
Year-on-year quarterly revenue growth grew by 250.7%, now sitting on 35.87M for the twelve trailing months.
Volume
Today's last reported volume for EuroDry Ltd. is 19611 which is 62.46% below its average volume of 52252.
EuroDry Ltd.'s sales growth for the next quarter is 164.8%. The company's growth estimates for the current quarter and the next is 6400% and 1206.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.14%.
Volatility
EuroDry Ltd.'s last day, last week, and last month's current intraday variation average was 3.71%, 4.14%, and 5.18%, respectively.
EuroDry Ltd.'s highest amplitude of average volatility was 3.98% (day), 7.70% (last week), and 9.81% (last month), respectively.
EuroDry Ltd.'s Stock Yearly Top and Bottom Value
EuroDry Ltd.'s stock is valued at $21.02 at 15:22 EST, way below its 52-week high of $34.65 and way above its 52-week low of $5.40.
EuroDry Ltd.'s Moving Average
EuroDry Ltd.'s worth is way under its 50-day moving average of $25.94 and below its 200-day moving average of $21.51.2. Pfizer (PFE)
108.8% sales growth and 14.03% return on equity
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide.
Pfizer's sales growth this year is anticipated to be 91.3% and a negative 12.9% for next year.
Year-on-year quarterly revenue growth grew by 44.6%, now sitting on 46.41B for the twelve trailing months.
Volume
Today's last reported volume for Pfizer is 88154300 which is 142.74% above its average volume of 36315500.
Pfizer's sales growth for the next quarter is 108.8%. The company's growth estimates for the present quarter and the next is 50% and 150%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.03%.
Volatility
Pfizer's last day, last week, and last month's current intraday variation average was 2.98%, 10.82%, and 7.18%, respectively.
Pfizer's highest amplitude of average volatility was 4.24% (day), 5.52% (last week), and 4.52% (last month), respectively.
Pfizer's Stock Yearly Top and Bottom Value
Pfizer's stock is valued at $59.48 at 15:22 EST, way higher than its 52-week high of $51.86.
Pfizer's Moving Average
Pfizer's worth is way above its 50-day moving average of $43.57 and way above its 200-day moving average of $42.49.Previous days news about Pfizer(PFE)
- Pfizer stops 70% omicron hospitalizations in s. africa study. According to Bloomberg Quint on Tuesday, 14 December, "A two-shot course of Pfizer Inc.'s vaccination may offer 70% protection against being hospitalized with the Covid-19 omicron variant, South Africa's largest medical-insurance provider Discovery Ltd. said."
- According to FXStreet on Tuesday, 14 December, "The fears have merged as the COVID-19 vaccines from AstraZeneca (AZN) or Pfizer (PFE) and BioNTech (BNTX) have been reported to besubstantially less effective at warding off omicron than earlier variants of the virus, CNBC has stated,citing a new University of Oxford study."
- Cathie wood sells $8.6m worth shares in Pfizer, buys coinbase and robinhood on the dip. According to Business Insider on Tuesday, 14 December, "Brokerage UBS upgraded Pfizer stock from a Neutral rating to a Buy rating and raised the price target to $60 a share from $52.", "Cathie Wood-led money managing firm Ark Invest on Monday sold 155,578 shares - estimated to be worth $8.59 million - in Pfizer Inc (NYSE:PFE) as the pharma stock closed a record high after a $6.7 billion acquisition."
- According to MarketWatch on Tuesday, 14 December, "Several big pharmaceutical companies, including COVID-19 vaccine makers Moderna and Pfizer were among the biggest gainers in the S&P 500 Monday."
3. Fresenius Medical Care AG (FMS)
27.6% sales growth and 9.51% return on equity
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally.
Fresenius Medical Care AG's sales growth this year is expected to be 19.2% and 4.6% for next year.
Year-on-year quarterly revenue growth declined by 5.2%, now sitting on 17.34B for the twelve trailing months.
Volume
Today's last reported volume for Fresenius Medical Care AG is 502175 which is 32.76% above its average volume of 378250.
Fresenius Medical Care AG's sales growth for the next quarter is 27.6%. The company's growth estimates for the current quarter and the next is a negative 26% and negative -24.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.51%.
Volatility
Fresenius Medical Care AG's last day, last week, and last month's current intraday variation average was 0.20%, 0.68%, and 0.69%, respectively.
Fresenius Medical Care AG's highest amplitude of average volatility was 1.28% (day), 1.33% (last week), and 1.24% (last month), respectively.
Fresenius Medical Care AG's Stock Yearly Top and Bottom Value
Fresenius Medical Care AG's stock is valued at $30.51 at 15:22 EST, way under its 52-week high of $43.33 and higher than its 52-week low of $29.71.
Fresenius Medical Care AG's Moving Average
Fresenius Medical Care AG's worth is below its 50-day moving average of $33.36 and way under its 200-day moving average of $37.59.4. PayPal (PYPL)
18.7% sales growth and 24.3% return on equity
PayPal Holdings, Inc. operates as a technology platform and digital payments company that enables digital and mobile payments on behalf of consumers and merchants worldwide.
PayPal's sales growth this year is expected to be 20.3% and 22.8% for next year.
Year-on-year quarterly revenue growth grew by 13.2%, now sitting on 24.57B for the twelve trailing months.
Volume
Today's last reported volume for PayPal is 16260500 which is 12.1% above its average volume of 14504400.
PayPal's sales growth for the next quarter is 18.7%. The company's growth estimates for the present quarter and the next is a negative 0% and 17.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.3%.
Volatility
PayPal's last day, last week, and last month's current intraday variation average was 1.37%, 1.03%, and 2.04%, respectively.
PayPal's highest amplitude of average volatility was 3.21% (day), 3.04% (last week), and 3.39% (last month), respectively.
PayPal's Stock Yearly Top and Bottom Value
PayPal's stock is valued at $186.20 at 15:22 EST, way below its 52-week high of $310.16 and higher than its 52-week low of $179.15.
PayPal's Moving Average
PayPal's value is way under its 50-day moving average of $222.51 and way under its 200-day moving average of $258.16.Previous days news about PayPal(PYPL)
- We got an exclusive look at the 14-slide pitch deck ramp, a startup that wants to become the PayPal of crypto, used to raise $53 million. According to Business Insider on Wednesday, 15 December, "Ramp, a startup that describes itself as a PayPal of crypto, has raised $53 million in its second funding round in six months.", "Ramp compares its approach to that of Stripe or PayPal by allowing any website, app, or service to embed payment infrastructure into their existing systems. "
- Looking at PayPal holdings's recent whale trades. According to Benzinga on Thursday, 16 December, "This data can help you track the liquidity and interest for PayPal Holdings's options for a given strike price. ", "Today, Benzinga's options scanner spotted 39 uncommon options trades for PayPal Holdings."
- PayPal, affirm scrutinized over ‘buy now, pay later’ by CFPB. According to Bloomberg Quint on Thursday, 16 December, "Spokespeople for PayPal and Afterpay did not immediately respond to requests for comment."
- According to MarketWatch on Wednesday, 15 December, "Additional investors in Anchorage Digital include Goldman Sachs ; Alameda Research; Andreessen Horowitz and Apollo credit funds ; as well as funds and accounts managed by BlackRock ; Blockchain Capital, Delta Blockchain Fund; Elad Gil; GIC, GoldenTree Asset Management; Innovius Capital; Kraken; Lux Capital; PayPal Ventures; Senator Investment Group; Standard Investments; Thoma Bravo; and Wellington Management. "
5. Sensata Technologies Holding N.V. Ordinary Shares (ST)
9.2% sales growth and 13.37% return on equity
Sensata Technologies Holding plc develops, manufactures, and sells sensors, sensor-based solutions, controls, and other products in the Americas, Europe, Asia, and internationally.
Sensata Technologies Holding N.V. Ordinary Shares's sales growth this year is expected to be 24.7% and 8.4% for next year.
Year-on-year quarterly revenue growth grew by 20.6%, now sitting on 3.79B for the twelve trailing months.
Volume
Today's last reported volume for Sensata Technologies Holding N.V. Ordinary Shares is 1822230 which is 121.38% above its average volume of 823121.
Sensata Technologies Holding N.V. Ordinary Shares's sales growth for the next quarter is 9.2%. The company's growth estimates for the ongoing quarter and the next is a negative 5.9% and 2.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.37%.
Volatility
Sensata Technologies Holding N.V. Ordinary Shares's last day, last week, and last month's current intraday variation average was 1.98%, 1.63%, and 1.79%, respectively.
Sensata Technologies Holding N.V. Ordinary Shares's highest amplitude of average volatility was 3.41% (day), 2.67% (last week), and 2.69% (last month), respectively.
Sensata Technologies Holding N.V. Ordinary Shares's Stock Yearly Top and Bottom Value
Sensata Technologies Holding N.V. Ordinary Shares's stock is valued at $57.19 at 15:22 EST, way below its 52-week high of $64.80 and way higher than its 52-week low of $49.14.